by Gary Chandler | Dec 24, 2021 | ALS
Accelerating Access to Critical Therapies President Biden just signed the Accelerating Access to Critical Therapies (ACT) for ALS Act. The bill will fund research into neurodegenerative disorders such as amyotrophic lateral sclerosis (ALS). The act will create a...
by Gary Chandler | May 31, 2014 | Alzheimer's Disease Research, Alzheimer's Disease Treatment
Prion Pioneer Prusiner Leads Research Daiichi Sankyo Co. Ltd. and University of California, San Francisco (UCSF) announced that they have established a drug discovery collaboration focused on developing novel therapeutics and molecular diagnostics for multiple...
